The conglomerate beat analysts' operating profit target, but there were no share buybacks over the third quarter.

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Berkshire Hathaway posts record Q3 2025 earnings as Warren Buffett prepares for succession. Discover key results, strategy, ...

Berkshire Hathaway shows strong profit growth, solid insurance and railroad performance, and a powerful cash position. Find ...

The biggest thing on most investors’ minds right now is that Buffett Vice Chair Greg Abel is set to succeed him as CEO in ...

Berkshire Hathaway (BRK-B, BRK-A) stock is in focus after the company reported earnings. CFRA Research vice president of equity research Cathy Seifert discusses key takeaways from the earnings print, ...

Berkshire Hathaway reported major stock sales last quarter. That includes a further reduction in one of Berkshire's top ...

Investors have long followed Buffett and team's stock picks via a massive portfolio within Berkshire Hathaway. Today, that ...

Supreme Court arguments over tariffs are coming, shutdown milestone approaches, China’s EV sales are slowing, and more news ...

Berkshire Hathaway also said that it did not make any stock buybacks in the first half of the year. Berkshire only buys back ...

Investors shouldn't replicate the concentration of Berkshire, but the following stocks could have a place in your portfolio.